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http://dx.doi.org/10.1016/j.fjs.2013.Summary Extramammary Paget’s disease (EMPD) is a tumor affecting mainly the genital re-
gion. Surgery remains the standard treatment for EMPD. Flaps were needed if there were
massive defect after appropriate wide excision, especially when the tumor was very extensive.
This study presents two cases of penoscrotal and perianal EMPD that needed flap reconstruc-
tion after wide excision of the tumor. Both cases were successfully reconstructed with flaps.
Copyright ª 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Extramammary Paget’s disease (EMPD) is a tumor affecting
mainly the genital region including the vulva, penis,
scrotum, and perianal area. Most patients with EMPD have a
good prognosis because the tumor cells generally extend
only into the epidermis. For patients with an in situ tumor,have no conflicts of interest
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06.007wide local excision with a safe margin is the treatment of
choice. However, a complete surgical excision is not always
practical because the reported local recurrence rate is still
high.1,2 Importantly, appropriate flap reconstruction after a
wide local excision is needed if the tumor is very extensive.
By contrast, a small proportion of EMPD is association with
underlying or internal visceral carcinomaconsis.3e5 Several
investigators posit the existence of primary and secondary
EMPD.6,7
In this study, we present two cases of penoscrotal and
perianal EMPD that needed flap reconstruction after wide
excision of the tumor.ciation. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 The initial lesion of the penoscrotal area of Case 1.
Figure 2 Wide excision of the tumor (total penectomy) in
Case 1.
Figure 3 The right gracilis myocutaneous pedicle flap was
designed for wound reconstruction in Case 1.
Penoscrotal and perianal EMPD 192. Case reports
2.1. Case 1
A 70-year-old male was admitted due to painless redness of
the penoscrotal region for about 10 years. The patient
complained of mild pain, heat sensation, and some
discharge at the lesion site (Fig. 1). Outpatient treatment
received elsewhere proved unsuccessful. Then the patient
came to our outpatient department for help. The initial
impression of condyloma was proven by biopsy on January
29, 2008. However, the symptoms failed to improve after 1
year. A second biopsy on July 24, 2009 showed Paget’s
disease. The patient was then admitted for further man-
agement. The preoperative survey, included pelvic
computed tomography and bone scan, showed no distal
metastasis. Cystoscope revealed no other lesion in the
bladder. Wide excison of the tumor (total penectomy) with
a safety margin and reconstruction by a pedicled gracilis
myocutaneous flap were done on August 11, 2009 (Figs.
2e4). Pathological examination showed infiltration of
nests of pagetoid neoplastic cells in the lower epidermis
with a margin free from disease (Fig. 5). The patient was
discharged on September 1, 2009. There has been no local
recurrence since this operation.
2.2. Case 2
A 69-year-old male with a history of diabetes mellitus and
hypertension was admitted due to a perianal mass which
had tended to bleed for about 2 years. He received treat-
ment at another outpatient department, but results were
not successful. There were perianal eczema and itching,
followed by a tendency to bleed (Fig. 6). The biopsy showed
Paget’s disease. No specific finding was found by rectal
scope. No obvious distal metastasis was found by pelvic
computed tomography scan. On October 1, 2009, a wide
excision of the perianal tumor with a 2 cm safety margin
was performed (Figs. 7 and 8). The wound was then
reconstructed using a bilateral posterior thigh V-Y flap
(Fig. 9). In addition, a temporary colostomy was done for
wound care. The wound healing progressed smoothly and
all sutures were removed after 3 weeks (Fig. 10). A physical
examination of the anus showed adequate sphincter func-
tion and it was wide enough to accept an index finger,
indicating an adequate diameter of the anus without
serious scar contracture. No local recurrence has been
noted.
2.3. Outcome
Both cases were successfully treated with a wide excision
of the tumor with a 2 cm safety margin and reconstructed
with a local flap.
3. Discussion
In 1874, Sir James Paget8 first described an intraepidermal
neoplasm of the nipple, caused by an underlying breast
carcinoma. Crocker9 described the first patient with EMPDinvolving the penis and scrotum in 1889. Perianal Paget’s
disease was first described in 1893.10 Other sites of occur-
rence include the vulva, scrotum, groin, and axilla.11,12
Due to different histogenesis, EMPD may be separated
into two types. In primary EMPD, the most common type,
there is no underlying carcinoma, and all lesions are
located in the intraepithelial level. The malignant cell is
suspected to originate from the intraepidermal apocrine
glands or from pluripotent cells of the epidermis. There is
the chance that the primary EMPD could invade the dermis
and metastasize via lymphatic spread. By contrast, if the
malignant cell is from an underlying apocrine carcinoma or
Figure 4 Case 1’s wound 1 week post operation.
Figure 6 Local perianal mass with bleeding tendency in
Case 2.
20 Y.-S. Lu et al.internal malignancy, it is called secondary EMPD. Common
visceral malignancies include carcinomas of the bladder,
rectum, urethra, cervix, and prostate. About 15% of cases
are associated with an underlying internal carcinoma.
EMPD often presents with a long-standing history of
pruritic, erythematous patches over the anogenital and
perineal areas, and always presents a poor response to
topical treatment. Biopsy is frequently delayed. Lesions
typically involve apocrine gland bearing skin such as the
vulva, perineal, scrotal, perianal, and penile skin.
The prognosis for primary EMPD without deep dermal
invasion is good with appropriate treatment. However,
invasive EMPD has a high rate of metastasis. The depth of
invasion is an important prognostic factor. The overall
survival rate is poor; if the invasion extends into the sub-
cutaneous tissue, and then regional lymph node metastases
may occur. In cases of secondary EMPD, prognosis is related
to the underlying carcinoma. According to the data of the
Veterans General Hospital, Taipei, Taiwan, six of 29 pa-
tients (20.7%) died of the scrotal EMPD and three (10.3%)Figure 5 Pathology of Case 1. (A) The biopsy specimen shows gro
and eosin, 100) that (B) shows nuclear enlargement with atypia,
and eosin, 400).died of associated malignancy. But there are still insuffi-
cient data about associated malignancy or the histological
characteristics of each lesion.13
Surgery remains the standard treatment for EMPD.
However, high local recurrence rates are seen after a wide
surgical excision with an adequate margin. This could be
due to irregular margins or the multifocal nature of EMPD.
Several papers have shown an overall recurrence rate of
about 40% with a wide local excision.12,14 Local recurrence
rates are higher in cases of invasive disease compared to
those limited to intraepithelial involvement. More radical
and extensive surgeries are associated with lower rates of
local recurrence.
Mohs micrographic surgical excision (MMS) both improves
cure rates and spares tissue around critical genitourinary
structures.15 The recurrence rate after treatment with MMS
is reported in 16% of primary EMPD. In 97% of cases treated
with MMS, a safe margin of about 5 cm should be excised
from the clinical tumor margin. With a surgical margin of
2 cm, only 59% of tumors are cleared, and the other 41% of
EMPD are treated with the standard wide excision.ups, clusters, or single cells within the epidermis (hematoxylin
prominent nucleoli, and pale-staining cytoplasm (hematoxylin
Figure 7 The wound after wide excision of Case 2’s tumor. Figure 9 Bilateral posterior thigh V-Y fasciocutaneous flap is
designed for wound reconstruction in Case 2.
Figure 10 All Case 2’s sutures were removed after 3 weeks.
No scar contracture of the anus is noted.
Penoscrotal and perianal EMPD 21The two cases in this study had noninvasive primary
EMPD. Due to the large tumor, both cases accepted a wide
excision with a 2 cm safety margin. The defect was so big
that a local flap was used for reconstruction. If we choose
the 5 cm safety margin, the destruction around the critical
genitourinary structures wound is very severe. We need to
think about the balance between the benefit and the
destruction of a large safe margin. Even if we use the 5 cm
safety margin, local recurrence still could happen. It has
not been proven whether more extensive surgery would be
more effective in preventing local recurrence; the value of
excision wider than a 3 cm safe margin is controversial. The
recurrence rate has been reported to be about 12.5% in 24
patients who received wide local excision and the excision
margin varied from 1 cm to 5 cm.13
Although surgery remains the traditional treatment for
EMPD, radiotherapy may be used when patients are poor
surgical candidates or when the level of genitourinary
function after extensive surgery is a concern.16 Radio-
therapy has also been used for local recurrence after sur-
gery or as an adjuvant therapy in patients with a high risk of
local recurrence.16
The experience of chemotherapy for EMPD still relies on
case reports. Systemic chemotherapy has been used to
treat patients with invasive and metastatic disease and may
be considered in rare cases when surgery and radiotherapy
are contraindicated. Limited reports of systemicFigure 8 Case 2’s biopsy specimen showed tumor with 2 cm
safe margin.chemotherapy to treat EMPD have been described,
including a combination of low dose 5-fluorouracil and
cisplatin17; a combination of 5- fluorouracil, cisplatin,
mitomycin C, epirubicin, and vincristine18; and docetaxel.19
In conclusion, most EMPD cases have a good prognosis,
with noninvasive EMPD being treated with surgical excision
and careful evaluation of the tumor margin. Invasion level
and lymph node metastasis are important prognostic fac-
tors in EMPD. Because no effective therapy yet exists for
widely metastatic disease, the therapeutic strategy for
advanced EMPD requires further investigation.References
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